Dassault Systèmes has announced plans to commercially release the first simulated human heart from its Living Heart Project on 29 May.
Developed using Dassault’s 3DEXPERIENCE platform’s realistic simulation applications, the high-fidelity 3D simulator of a four-chamber human heart will enable device manufacturers, researchers and medical professionals to perform virtual tests and visualise the heart’s response in ways that are not possible with legacy physical testing.
Dassault Systèmes SIMULIA CEO Scott Berkey said: "The availability of the first commercial, physics-based simulated heart marks a significant milestone for digital medical tools that will advance cardiovascular science and directly impact the quality of life of patients.
"The Living Heart Project is proof that our technology can potentially change the course of therapies through simulation of the human body.
"We will continue to collaborate with the biomedical community and our partners to provide technology and applications that will enhance the experience for heart patients everywhere."
Representing a baseline healthy heart, the model comprises well-defined anatomic details of the heart and proximal vasculature such as the aortic arch, pulmonary artery, and superior vena cava, and can be used to study congenital defects or heart disease by altering the shape and tissue properties in an easy-to-use software editor.
In addition, the scientifically validated simulator facilitates insertion of medical devices to study their influence on cardiac function, validate their efficacy and predict reliability under a range of operating conditions.
The dynamic response of the heart model is governed by realistic electrical, structural and fluid flow physics.
Started in 2014, the Living Heart Project includes 45 members, comprising regulatory science focused organisations such as US Food and Drug Administration and the Medical Device Innovation Consortium, as well as technology providers, cardiologists, medical device manufacturers and hospitals such as St Jude Medical and Mayo Clinic.
According to Dassault, the crowdsourcing approach allowed the heart model to be independently tested and included in peer-reviewed scientific journals by project members.
Image: Dassault’s scientifically validated 3D heart model will accelerate device testing and research for the treatment of heart disease. Photo: courtesy of Dassault Systèmes.